NVSNovartis AG
What is the market doing?
No clear lean: rangebound and a token position.
Rangebound, no clear trend. Price is −3% vs its 200-day average.
A token position, settled Sep 15, 2026, a few days of normal trading to cover. Down 7.6% since the previous count, unchanged over three months.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NVS is trading
Novartis AG is +20% over the past year while the S&P 500 is +18%: 2.2 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −2.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 59
RSI (14) · neutral
- Below its 52-week high
- 12%
Below its 52-week high
Details›
- Last close2026-10-09
- $143.73
- 1 monthS&P 500 +2.7%
- +4.5%
- 1 yearS&P 500 +18%
- +20%
- 5 yearsS&P 500 +88%
- +103%
- vs 50-day average$148.92
- −3.5%
- 52-week high
- $163.64
- 52-week low
- $118.20
- Annualised volatility
- 23%
| Year | Return |
|---|---|
| 2026 (year to date) | +7.4% |
| 2025 | +47% |
| 2024 | +0.02% |
| 2023 | +16% |
| 2022 | +8.1% |
| 2021 | −3.7% |
| 2020 | +3.3% |
| 2019 | +27% |
| 2018 | +5.9% |
| 2017 | +19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +2.4% |
| Feb | 10 | 5 of 10 | −0.51% |
| Mar | 10 | 7 of 10 | +3.1% |
| Apr | 10 | 6 of 10 | +0.73% |
| May | 10 | 8 of 10 | +2.1% |
| Jun | 10 | 8 of 10 | +2.2% |
| Jul | 11 | 9 of 11 | +1.5% |
| Aug | 11 | 3 of 11 | +0.01% |
| Sep | 11 | 6 of 11 | −2.0% |
| Oct | 11 | 5 of 11 | −2.8% |
| Nov | 10 | 7 of 10 | +4.1% |
| Dec | 10 | 7 of 10 | +1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, General
Ranks #2 of 7 by RyuScore